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Pegbovigrastim injection (IMR) represents a new approach in overcoming mastitis. The
objective of this study was to evaluate production parameters, overall health, time to first
detected heat, and behavior of cows treated with IMR or a saline control. Study cows (n = 270)
were blocked by parity group (multiparous or primiparous) and randomly assigned to control
(CON, n = 144) or treatment (IMR, n = 126). Milk yield, fat, protein, lactose, solids nonfat
percent, somatic cell count, and body condition, hygiene, and lameness were evaluated weekly.
Animals were evaluated for metritis twice weekly via evaluation of rectal temperature, per
rectum palpation, and uterine discharge until 30 days in milk. Farm staff recorded occurrence of
other diseases. Neck tag and a leg tag, each with activity monitoring sensors, measured behavior
and time to first detected estrus. The occurrence of clinical mastitis did not differ between
treatments. Treated cows were 2.46 times more likely to develop metritis compared to control
cows. Cows given IMR had increased odds of developing metritis, without altering mastitis
occurrence, production parameters, behavior, and time to first heat in lactating dairy cows.
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CHAPTER I
LITERATURE REVIEW
The transition period in dairy cows
According to Drackley (1999), the biology of the dairy cow during the transition period
represents "the new frontier" faced by the dairy industry. The same author explains that the
transition period is poorly understood when compared to the knowledge of dairy cows during
and after peak lactation. Hypocalcemia, ketosis, fatty liver, and displaced abomasum are
metabolic diseases faced by cows mainly during this period and negatively impact the
profitability of dairy operations (Mulligan and Doherty, 2008). Immunosuppression during the
pre-partum period can increase susceptibility of dairy cows having mastitis, retained placenta,
and metritis during early lactation (Kehrli and Roth, 1989; Kehrli et al., 1989). Metabolic and
infectious diseases are linked etiologically, and unfortunately, this interrelationship regularly
results in “cascade effects,” in which the occurrence of a certain disease increases the odds of
other diseases to occur (Goff and Horst, 1996). Additionally, reduced fertility, reduced milk
production, and increased incidence of lameness are consequences of this cascade effect
(Mulligan and Doherty, 2008).
Over the past several decades, dairy cattle have been selected for increased milk
production. Such great milk production is possible because of the nutrients of the diet and
mobilization of body tissue reserves, and without the ability to mobilize body reserves and the
1

nutrients from the diet, dairy cows would not be able to meet their genetic potential (Kelton et
al., 1998).
The physiological shift from a state of pregnant and non-lactating to non-pregnant and
lactating is possible due to a phenomenon that Bauman and Currie (1980) termed homeorhesis.
These authors defined homeorhesis as “coordinated and orchestrated changes in body tissues
metabolism required to support a particular physiological status.” The transition from late
gestation to early lactation is a classic example of homeorhesis.
Nutrient demand from the mammary gland of high-producing dairy cows exceeds that of
the rest of the body. The nutrient needs of the mammary tissue are of such magnitude that Brow
(1969) suggested that the cow should be considered an appendage on the udder, rather than the
reverse. At the onset of lactation, important modifications in the partitioning of nutrients and
metabolism of the whole cow must occur to meet demands of the mammary gland (Convey,
1974). Physiological adaptations involve most of the body tissues and relate to the metabolism of
all nutrient classes: protein, lipids, carbohydrates, vitamins, and minerals (Bauman, 2000).
The metabolic adaptations occurring with the onset of lactation are related to hormonal
changes occurring throughout this period. Some of the hormone changes include: 1) decreased
insulin; 2) increased somatotropin; 3) increased prolactin; 4) increased glucocorticoids; 5)
decreased thyroid hormones; and 6) decreased insulin-like growth factor 1 (Petterson et al.,
1993). These hormonal changes lead to greater uptake of nutrients by the mammary gland.
Interestingly, virtually all of the glucose produced in the liver is directed to the mammary gland
(Bell, 1995). During lactation, less glucose is made available to other cells like the immune
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system. The most common metabolic changes that dairy cows face during the transition from
gestation to lactation is summarized in Table 1.
The inability to adjust the metabolism quickly enough to meet the demands of the fetus
and the mammary gland frequently results in acute and subclinical metabolic disorders (Bauman
and Currie, 1985). Twenty years after Drackley (1999) described the transition period as “the
new frontier” in dairy science, much still remains to be discovered. However, it is still of great
importance considering 30 to 50% of cows in North America suffer from a metabolic or
infectious disease in the weeks following calving (LeBlanc, 2010).
Negative energy balance and metabolic diseases in dairy cattle
Energy balance is the relationship between the energy in (calories taken into the body
through feed) and energy out (calories being used in the body for maintenance, growth, and
lactation). This relationship, defined by the laws of thermodynamics, dictates whether weight is
lost, gained, or remains the same (Bauman, 1984). Most cows in their transition period are in
negative energy balance (NEB) (Ospina et al., 2010), meaning the amount of energy consumed
in the diet does not make up for energy expenditure. Severe NEB can result in increased
incidence of infectious and metabolic diseases during the transition period (LeBlanc, 2010).
Infectious diseases like metritis (Huzzey et al., 2007) and mastitis (Kehrli, 1991; Pyorala, 2008)
and metabolic diseases like hypocalcemia (Reinhardt et al., 2011) and hyperketonemia (Sheehy
et al., 2016) are highly prevalent during the transition period and can lead to productive and
economic losses (McArt et al., 2015; Liang et al., 2017).
During the last three weeks of gestation, the nutrient requirements for fetal development
reach their peak (Bell, 1995). Additionally, synthesis of colostrum and milk further increases the
3

energy requirement by almost two times (NRC, 2001). For instance, the Nutrient Requirement
Council estimates that the net energy of lactation requirement for a 570 kg primiparous cow two
days before calving is 58.5 megajoule (MJ)/d. The energy required for the same animal to
produce 20 kg of 4% fat milk two days after calving is 105.0 MJ/d (NRC, 2001). Despite the
increase in requirements, cows typically decrease their average dry matter intake by 10 to 30%
after calving (Drackley et al., 2005; Huzzey et al., 2007), further intensifying NEB. The
decreased dry matter intake in the last weeks of gestation is partially explained by the fetus size,
which takes abdominal space, and consequently, decreases the amount of feed the rumen can
hold (Block, 2010). Nevertheless, the decreased dry matter intake is mainly attributed to the
hormonal alterations and physiological changes that happen in the periparturient period (Bertics
et al., 1992; Grant, 1995).
The NEB stimulates cows to mobilize body fat in the form of non-esterified fatty acids
(NEFA), causing a subsequent accumulation of beta-hydroxybutyric acid (BHBA) in the blood.
Both NEFA and BHBA are important energy metabolites that are traditionally used as indicators
of NEB during the transition period (Duffield et al., 2009). During the transition from pregnancy
to lactation a natural increase of NEFA and BHBA concentrations occur in the blood,
particularly in high-yielding dairy cows (Bell, 1995). However, an excessive increase of these
metabolites is often associated with metabolic syndromes, like fatty liver, ketosis, and displaced
abomasum (Mulligan and Doherty, 2007), as well as decreased milk production (Kelton et al.,
1998), and poor reproductive performance (LeBlanc, 2010).
Ketosis, or hyperketonemia, is a disease related to fat metabolism and typically occurs in
dairy cows in early lactation (McArt, 2012). Intense NEB leads to adipose mobilization, which
leads to an increase in NEFA concentration in the blood (Bauman, 1984). Serum NEFA is
4

directed to the synthesis of ketone bodies in the liver, like BHBA, acetoacetate, and acetone
(Bauman, 1984).
Clinical ketosis manifests as a decrease in appetite, weight loss, and a decrease in milk
production (McArt, 2012), and its incidence in the United States has been reported to be between
2 and 3% (McLaren et al., 2006; Seifi et al., 2011). Nevertheless, cows are more likely to suffer
from subclinical ketosis, which is defined as an excess of circulating ketone bodies in the blood
without clinical signs (Andersson, 1988). Incidence of subclinical ketosis has been estimated to
average 43% (McArt et al., 2012), ranging from 26 to 56% with peak incidence of subclinical
ketosis occuring at 5 DIM (McArt et al., 2011).
Measuring BHBA is considered the gold standard for ketosis detection because this
ketone body is more stable in blood than acetone or acetoacetate (Tyopponen and Kauppinen,
1980). The most common cut point used to define subclinical ketosis is serum BHBA
concentrations greater than 1,000 μmol/L (Duffield et al., 2009). Nevertheless, Duffield et al.
(2009) explained that in order to predict health risk in early lactation dairy cows, hyperketonemia
should be defined at a BHBA serum concentration greater than 1,200 μmol/L, instead of 1,000
μmol/L.
Cows in early lactation with blood BHBA concentrations above 1,200 μmol/L have
increased risk of developing displaced abomasum (DA) and metritis (Duffield et al., 2009;
Ospina et al., 2010). In the first 30 DIM, 0.3% of cows without subclinical ketosis developed
DA, while 6.5% of cows with subclinical ketosis developed DA (McArt et al., 2012).
Furthermore, cows that tested positive for subclinical ketosis were 19.3 times more likely to
develop a DA than cows without ketosis (McArt et al., 2012).
5

Excessive mobilization of fatty acids from adipose tissue, due to intense NEB, can result
in accumulation of triacylglycerol (TAG) in hepatocytes and cause impairment of liver function
(Mulligan and Doherty, 2007). Fatty liver, or hepatic lipidosis, is recognized as a major
metabolic disease of dairy cows (Drackley, 1999). In dairy cows, fatty liver typically occurs in
the first 4 weeks after calving (Grummer, 1993). It is estimated that 50% of all cows have some
accumulation of TAG in the liver (Jorritsma et al., 2000; Jorritsma et al., 2001).
Bobe et al., (2004) defined fatty liver as “the percentage of TAG that causes detrimental
effects to the health, productivity, and reproductive success of a cow.” The same authors
explained that fatty liver could be classified based on the percentage of TAG in the liver and
categorized as normal liver (less 1%), mild fatty liver (1 to 5%), moderate fatty liver (5 to 10%),
and severe fatty liver (more than 10%) (Bobe et al., 2004). Accumulation of triglycerides greater
than 1% of liver is significant for dairy cows as approximately 85% of glucose for metabolism is
derived from the liver (Mulligan and Doherty, 2007).
The average cost of fatty liver was estimated to be $145/case (Guard, 1994). Annually,
the disease is estimated to cost over 60 million dollars to the dairy industry (Guard, 1994). Fatty
liver is associated with other metabolic diseases, in particular DA and ketosis (Bobe et al., 2004).
With all of these metabolic disorders, cows either are or will be in a severe NEB (Bobe et al.,
2004). Fatty liver has also been associated with infectious diseases, as it increased duration of
mastitis by three days (Hill et al., 1985) and increased severity of metritis (Haraszti et al., 1982).
Displaced abomasum is a disorder in cattle in which the abomasum, or the “true
stomach,” becomes distended with fluid or gas and shifts to an abnormal position (Weir and
McNish, 1960). In healthy cattle, the abomasum lays on the abdominal floor (Dirsken, 1962).
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Because of the natural anatomy of cattle, it is more common for the abomasum to displace to the
left, known as a left-displaced abomasum, rather than to the right (Weir and McNish, 1960).
When the abomasum moves from its normal position, it prevents the natural passage of gas and
feed through the digestive system, creating a restriction that, if not treated, can lead to death
(Dirsken, 1962). The treatment of these conditions usually involves abdominal surgery to correct
the displacement (Weir and McNish, 1960).
The incidence of DA is typically reported in the range of 3.5% to 5.0% (Goff, 2006; Van
Winden, 2002). The economic cost of DA is usually the result of reduced milk yield, direct costs
of treatment, and replacement costs due to premature culling (Sharver, 1997). In a stochastic
model, Liang et al. (2017) estimated that the average left displaced abomasum costs per case
were $432.48 ± 101.94 for primiparous cows, and $639.51 ± 114.10 for multiparous cows. The
authors also explained that the greatest portion of the cost comes from veterinary treatment
($197.22 ± 70.28 per case). Interestingly, Seifi et al., 2011 found that concentration of calcium
bellow 2.2 mmol/L in the first 2 weeks post-partum were at greater risk for developing DA
Furthermore, cows with serum BHBA greater than 1,000 mol/L displayed 13.6 times greater
odds of developing DA than cows with values below 1,000 mol/L.
Recent researchers have tested different feed strategies to reduce incidence of metabolic
disease in cattle. Selenium and vitamin E supplementation (Robert et al., 1989), monensin
(Duffield et al., 2003), or propylene glycol (Vaughn et al., 1993) may help in decreasing
incidence of metabolic diseases, but results are not consistent. Hence, increasing dry matter
intake and thus reducing NEB severity is still the best known strategy to reduce incidence of
metabolic diseases like ketosis, fatty liver, and DA (Drackley, 1999).
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Periparturient immune suppression in dairy cows
Two weeks before calving, the cow’s defense mechanisms begin to weaken, reaching
maximum suppression at parturition (Kehrli and Roth, 1989). The immune system remains
suppressed until three weeks after calving (Kehrli and Roth, 1989). These changes are associated
with alterations in hormone profiles, stress of parturition, and NEB (Mallard et al., 1997).
Consequently, immune cells are impaired during the transition period (Kehrli et al., 1989; Kehrli
and Roth, 1989).
During the transition period, several functions of polymorphonuclear cells (PMN),
especially neutrophils, are debilitated. The number of immature neutrophils in circulation
increases, whereas the number of mature neutrophils in the blood decreases (Paape et al., 2002;
Schukken et al., 2011). The synthesis of reactive oxygen species is reduced from one week
before calving over the first two weeks after calving (Hoeben et al., 2000; Mehrzad et al. 2002),
and the proportion of PMN expressing the adhesion receptor L-selectin, necessary for
penetration of the cells at the site of infection, is diminished (Diez-Fraile et al., 2004). The
suppression of several functions of bovine’s PMN can be the cause of postpartum diseases like
mastitis, retained placenta, and metritis (Kehrli et al., 1989).
Some investigators have hypothesized that the increase in circulating glucocorticoids at
parturition is the main cause of immunosuppression (Burton et al., 2005; Weber et al., 2006).
However, glucocorticoids are elevated for approximately 24 hours around the time of calving
(Graugnard et al., 2012; Moyes et al., 2014). Thus, glucocorticoids alone cannot be the only
factor causing immunosuppression in transition dairy cows. As mentioned previously, major
changes in blood metabolites in transition dairy cows include increased concentration of NEFA
and BHBA, as well as prioritization of glucose to the mammary gland rather than peripheral
8

tissues (Bell, 1995). Immune cells have a preference for glucose as an energy source
(Newsholme et al., 1986; Newsholme et al., 1987). Glucose may have certain stimulatory effects
in immune cells, including increased proliferation and differentiation of leukocytes, like T- and
B-lymphocytes, and improved neutrophil chemotaxis and phagocytosis (Barghouthi et al., 1995;
Pithon-Curi et al., 2004). In humans, Wolowczuk et al. (2008) stated that glucose should be
considered quantitatively the most important fuel to fulfill the energy requirement of immune
cells. The same authors explained how an effective immune response requires an increase in
cellular proliferative, biosynthetic, and secretory activities, all processes that require great energy
consumption. Interestingly, it was recently reported that increased extracellular concentrations of
glucose can protect neutrophils from apoptotic death and that this protective effect is correlated
with the rate of glucose utilization by the cells (Healy et al., 2002).
Beta-hydroxybutyrate is negatively associated with the immune response because,
besides not being the favorite source of energy to immune cells (Newsholme et al., 1987),
elevated concentrations of BHBA can reduce neutrophils functions. For instance, it reduces extra
cellular trap formation, chemotaxis, and phagocytosis (Grinberg et al., 2008; Ingvartsen and
Moyes, 2015). Due to increased requirements by the mammary gland, glucose availability for the
immune system is less during the early postpartum period, whereas blood concentration of
BHBA and NEFA are increased. This may partly explain the naturally-occurring
immunosuppression dairy cows experience postpartum (Ingvartsen and Moyes, 2015).
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Mastitis postpartum
1) Cause
The term mastitis refers to the inflammation of the mammary gland. This term is derived
from the Greek words mastos (meaning breast) and itis (meaning inflammation of). Physical
trauma and chemical irritants can cause mastitis (NMC, 2002). However, most mastitis cases
occur when microbes (bacteria and fungus) enter the teat opening and successfully establish an
infection in the alveoli of the mammary gland (Harmon, 1994). The inflammation of the
mammary tissue is an immune reaction that occurs in response to the infection, in an attempt to
destroy or neutralize the invasive microbes (NMC, 2002). The inflammatory response consists of
an increase in blood proteins and white blood cells in the mammary tissue and the milk, and the
purpose of the response is to destroy the irritant, repair the damaged-tissue, and return the udder
to its pre-mastitis function (Harmon, 1994).
Cows with subclinical mastitis have no visible changes in the appearance of milk or the
udder, but milk production decreases, somatic cell count (SCC) increases, pathogens are present
in the secretion, and milk composition is altered (NMC, 2002). Clinical mastitis is defined by
abnormal milk, with watery appearance, presence of flakes, clots, or pus, and with varying
degrees of mammary gland inflammation, like redness, heat, swelling, and pain. Clinical mastitis
may or may not be accompanied by systemic illness (Tyler and Cullor, 1990).
Cows are at highest risk of developing clinical mastitis around parturition (Smith et al.,
1985; Bradley and Green 2004; McDougall et al., 2007). The interval from two weeks before
calving to three weeks after calving is considered to be the most critical period for the health of
the mammary gland (Oliver and Sordillo, 1988). Furthermore, during colostrogenesis, the
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susceptibility of the mammary gland to infections increases because the teat canal starts to open
and can leak colostrum (Oliver and Sordillo 1988).
2) Consequences
Mastitis resulting from major pathogens causes considerable compositional changes in
milk (Jones et al., 1984). The protein content is largely altered, as casein, the major milk protein,
decreases and whey proteins increase (Kitchen, 1981). Furthermore, serum albumin,
immunoglobulins, transferrin, and other serum proteins pass into milk because vascular
permeability is altered (Batavani et al., 2007). Lactoferrin, which has antibacterial properties due
to its iron-binding properties, increases in concentration. This increase is likely because of
increased output by the mammary tissue and a minor contribution from PMN (Kawai, 1999).
The breakdown of milk protein can occur from cows with clinical or subclinical mastitis
due to presence of proteolytic enzymes. Deterioration of milk protein as a result of mastitis may
continue during processing and storage (Bramley et al., 1996). Potassium, normally the
predominant mineral in milk, is reduced. Calcium also can decrease (Batavani et al., 2007). The
alteration on protein composition, caused by mastitis, negatively impacts the quality of dairy
products, like yield, flavor and quality (Bramley et al., 1996, Chagunda et al., 2006, Bansal et al.,
2007). Bramley et al. (1996) explained that the dairy industry must supply milk that is free of
antibiotics or adulterants, low in bacteria and SCC, and excellent in quality and flavor to
maintain a positive consumer image. Mastitis also compromises animal welfare (Chagunda et
al., 2006, Hogeveen et al., 2011), which may further damage the image of the dairy industry to
consumers (Hogeveen et al., 2011).
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Enhancing environmental hygiene and improving milking techniques are typical
measures in preventing mastitis occurrence. Blanket dry-cow therapy, or infusing antibiotics into
all quarters of all cows at the end of the lactation, has proven to be the most effective means of
eliminating existing infections and preventing new infections during the dry period (NMC,
2002). Nevertheless, occurrence of clinical mastitis postpartum remains high (Smith et al. 1985;
Bradley and Green 2004; McDougall et al. 2007). Because of the increased incidence of mastitis
in the periparturient period, strategies that aid in mastitis prevention are needed, but currently
lacking. Enhancing the immune response of dairy cows might represent another strategy in
avoiding mastitis and its consequences.
Periparturient reproductive disorders
1) Retained placenta
Fetal membranes, or the placenta, represent an essential organ for prenatal transfer of
nutrients and oxygen from the dam to the fetus (Wooding, 1992). The term placenta is borrowed
from Latin placenta (meaning flat cake), because of the flat round shape of this organ afterbirth
(George, 1997). The placenta functions as a fetal-maternal organ with two components: the fetal
placenta (Chorion frondosum), which develops from the same blastocyst that forms the fetus,
and the maternal placenta (Decidua basalis), which develops from the maternal uterine tissue
(Peter, 2013). The release of fetal membranes postpartum is a physiological process and involves
loss of the feto-maternal adherence, combined with contraction of uterine musculature (El-Malky
et al., 2010). This release is usually accomplished within 3 to 9 hours after calving (El-Malky et
al., 2010).
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Retained placenta (RP) is a reproductive abnormality unique to the cow and water
buffalo among domestic ruminants (Laven and Peters, 1996). In the United States, published
surveys (NAHMS, 2014) indicate that the incidence of RP reported for dairy cows was 4.5 ±
0.4%. However, researchers report the incidence of RP to vary between 3 and 39% of all
parturitions (Paisley et al., 1986; Eiler, 1997; Noakes et al., 2001). Incidence of RP is influenced
depending on the definition utilized (Grunert, 1986, Laven and Peters, 1996).
Grunet (1986) defined RP as failure to expel fetal membranes within 24 hours after
parturition (Grunert 1986), although other researchers found that retention of fetal membranes
for longer than 12 hours can be considered as pathological (Wetherill et al., 1965). Retained
placenta delays the postpartum resumption of cyclic ovarian function and prolongs the interval
from calving to first ovulation (Opsomer et al., 2000). Retained placenta, metritis, and
endometritis typically result in the late involution of the uterus and late regression of the ovarian
corpus luteum after calving.
Causes of RP are not fully understood, but abortion (Muller and Owens, 1974), dystocia
(Wetherill, 1965), fat cow syndrome (Markusfeld, 1987), increased parity (Markusfeld, 1987),
twin birth, stillbirth, hypocalcemia, and increased environmental temperature (Boyd and Sellers,
1948; Markusfeld, 1987) all can increase the risk of RP.
Gunnink (1984) proposed an interesting theory that after calving, when the placental
blood supply is terminated, the placenta becomes a “foreign body.” The author proposed that the
dam’s immune system needs to recognize and attack the fetal membranes as a foreign organism
in order to expel it. Additionally, Romaniukowa (1984) found that neutrophils from cows that
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developed RP had a decreased response to chemo-attractants and decreased ingestion capacity.
Kimura et al. (2014) demonstrated that cows developing RP have impaired neutrophil function.
2) Metritis
Metritis is often associated with retained placenta (Sheldon, 2004), caesarian sections
(Hussain et al., 1990), twins, and stillbirths (Markusfeld, 1987). Clinical signs of metritis include
pyrexia and fetid pus within the uterine lumen, vagina, or discharging from the vulva (Sheldon
and Dobson, 2004). This usually occurs within the first week of calving (Sheldon, 2004) and can
result in delayed uterine involution (Sheldon, 2004; Sheldon and Dobson, 2004).
During pregnancy, the uterus is sterile because the vulva, vestibule, vagina, and cervix
act as physical barriers to bacteria ascending into the genital tract (BonDurant, 1999; Sheldon,
2004). However, when the vulva is relaxed and the cervix is dilated during and after parturition,
environmental bacteria can contaminate the uterine lumen (Sheldon and Dobson, 2004). The
cervix remains dilated for several days (Sheldon, 2004). Consequently, virtually all cows are
found to have aerobic or anaerobic bacteria in the uterine endometrial tissue in the first 15 days
after calving (Elliot et al., 1974).
Clinical metritis occurs in up to 40% of dairy cows within a week of parturition.
However, metritis incidence depends on the definition used. According to large survey reports,
ocurrence of clinical signs of metritis ranges between 36 and 50% (Elliot et al., 1974; Olson et
al., 1984). However, when metritis is defined as abnormal discharged followed by signs of
systemic illness, like fever and anorexia, this range drops to 18.5% to 21% (Ruder et al., 1981;
Griffin et al., 1974).
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As an alternative classification, Sheldon et al. (2009) suggested that cows should be
classified as having “grade 1” metritis if they have an abnormally enlarged uterus and a purulent
uterine discharge without any systemic signs of ill health. Animals with additional signs of
systemic illness, like decreased milk yield, dullness, and fever (rectal temperature < 39.5°C) are
classified as having “grade 2” clinical metritis. Animals with signs of toxemia like anorexia, cold
extremities, depression, and/or collapse should be classified as having “grade 3” metritis, which
had been reported to have poor prognosis.
Several health problems are associated with metritis. Metritis incidence may increase risk
of milk fever (1 to 2 times; Curds et al., 1985), retained placenta (5 to 6 times; Erb et al., 1985;
Erb, 1987), and displaced abomasum (3 to 4 times; Markusfeld, 1986). Furthermore, metritis
may increase days to first service, days to conception, and reduced conception rate at first service
by one-half when compared to cows without metritis (Erb et al., 1985; Erb, 1987).
Unfortunately, the terms metritis and endometritis have often incorrectly been used
interchangeably, whereas each has a clear definition. Although both metritis and endometritis are
recognized by presence of abnormal discharge in the vulva, endometritis is a superficial
inflammation of the endometrium, which extends no deeper than the stratum spongiosum
(Sheldon, 2004). Moreover, clinical metritis is characterized by abnormal, fetid, purulent
discharge leaving the vulva in the first 21 days after calving (Sheldon, 2004). Clinical
endometritis, on the other hand, is characterized by presence of purulent (>50% pus) uterine
discharge detectable in the vagina 21 days or more after parturition, or mucuopurulent
(approximately 50% pus, 50% mucus) discharge detectable in the vagina after 26 days
postpartum (Sheldon, 2004). Endometritis incidence ranges from 10 to 20% in dairy cattle
(Borsberry and Dobson, 1984; LeBlanc, 2002). In a Canadian study, the first service conception
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rate was lower for cows with endometritis (29.8 versus 37.9%), the median calving to conception
interval was longer (151 versus 119 days), and more animals were culled for failure to conceive
(6.7 versus 3.8%; LeBlanc, 2002). Polymorphonuclear neutrophils are the main effector cells for
removing microbes from the uterus after calving. Nevertheless, endocrine and metabolic changes
around the time of parturition in cattle modulate PMN phagocytic function and gene expression
(Burvenich, et al., 2007; Madsen, et al., 2002). Blood PMNs obtained from cows with
endometritis were significantly less phagocytic (Kim and Yang, 2005).
The immune response
According to the National Cancer Institution, the immune system is defined as “a
complex network of cells, tissues, organs, and the substances they synthesize that helps the body
fight infections and other diseases.” The main purpose of the immune system is to protect an
animal’s body from infectious disease (Parham, 2015). Infectious microorganisms that cause
disease are called pathogens, and they can be divided into four types: bacteria, viruses, fungi, and
internal parasites (Alberts et al., 2002). An animal’s body has successive lines of defense that
must be overcome if a pathogen is to establish successful infection (Hoffmann et al., 1999).
The skin is a tough barrier of epithelial cells protected by layers of keratinized cells and is
the first physical barrier (Denda, 2000). Although tough, the skin can be breached by physical
damage, like wounds, burns, or surgical procedures (Percival, 2002). After skin, the next
physical defense is the epithelial lining surface of the respiratory, gastrointestinal, and urogenital
tracts (Hoffmann et al., 1999). These surfaces are called mucosal surfaces because they are
continually bathed in mucus (Hoffmann et al., 1999). Epithelial cells produce mucus, and mucus
is made of glycoproteins, proteoglycans, and enzymes (Hoffmann et al., 1999). Mucus protects
the epithelial cells from damage and help limit infection rate (Magagoli, 2016; Parham, 2015).
16

The immune system is activated when skin and mucosa are breached and pathogens gain
access to the body’s soft tissues. The defenses of the innate and adaptive immune system must be
activated in order to avoid a successful pathogen infection (Parham, 2015). Cells involved in the
innate immune response include: macrophages, neutrophils, basophils, eosinophils, and natural
killer (NK) cells (Alberts et al., 2002). Cells involved in the adaptive immune response include
lymphocytes, like T-cells (cytotoxic and T-helper cells) and B-cells (plasma cells and memory
B-cells) (Alberts et al., 2002). Dendritic cells and macrophages link the innate and the adaptive
immune response (Parham, 2015).
The adaptive immune response, or acquired immunity, is highly specific for the pathogen
that induces them (Parham, 2015). Although it is slower to develop, the lymphocytes responsible
for the adaptive response have memory and will provide long-lasting protection (Alberts et al.,
2002). The adaptive immune response is only present in mammals and occurs after exposure to
an antigen either from a pathogen or vaccination (Alberts et al., 2002). When the innate immune
response is insufficient to control an infection, the adaptive immune response is activated
(Alberts et al., 2002).
Acquired immunity relies on the ability of immune cells to distinguish the animal cells
(self) and invaders microbes (non-self) (DeSilva and Clain, 2015). At the site of infection,
dendritic cells can detect antigens, or non-self-molecules, and trigger the onset of the adaptive
response (Parham, 2010). Dendritic cells and macrophages are professional presenting cells that
present antigens through major histocompatibility complex (MHC) molecules (Parham, 2010).
Through MHC molecules, dendritic cells display peptide fragments of pathogen to the cell
surface of T-cells (Iwasaki and Medzhitov, 2005). During this interaction, dendritic cells and
macrophages releases interleukin-1, which stimulate T-helper cell to release interleukin-2
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(Iwasaki and Medzhitov, 2005). The function of interleukin-2 is to stimulate proliferation of
cytotoxic T-cells and B-cells (Iwasaki and Medzhitov, 2005).
Via MHC molecules, cytotoxic T-cells are capable of recognizing and binding with
infected cells (Parham, 2010). Cytotoxic T-cells release chemicals that can kill infected cells
(Medzhitov, 2007). Differently than cytotoxic T-cells, T-helper cells do not kill cells or
pathogens (Medzhitov, 2007). Instead, T-helper cells activate B-cells and lead them to recognize
a particular antigen (Parham, 2010). B-cells undergo successive modifications and once they can
bind to a certain antigen, they receive additional signals from a helper T-cell and further
differentiates into an effector cell, known as a plasma cell (Parham, 2010). Plasma cells are
short-lived cells that may last for 5 days (Medzhitov, 2007). Plasma cells produce antibodies that
enter the blood stream and can bind to the antigen (Parham, 2010). Nevertheless, not all B-cells
become plasma cells. Indeed, certain B-cells become memory B-cells that may survive for
several decades (Iwasaki and Medzhitov, 2005). Long-lived memory B-cells have the ability to
recognize the same pathogen in case a re-infection occurs in the future (DeSilva and Clain,
2015). These specialized B-cells make the response for a secondary immune response faster and
more efficient (DeSilva and Clain, 2015). This powerful secondary immune response is what
gives immunity to some diseases after the animal has had it once or after they have been
vaccinated (DeSilva and Clain, 2015).
The cell receptors utilized to recognize pathogens is one of the main differences between
the innate and adaptive immune systems (Medzhitov, 2007). While acquired immune responses
take at least 5 to 7 days to be effective after an infection occurs, the innate immune responses
occur immediately after exposure to pathogens and serve as the first line of immune cells to
defend the host against microbes (Alberts et al., 2002).
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On the other side of the spectrum, certain bacteria, like Escherichia coli can double in as
little as 20 minutes under optimal growth conditions (Gibson, 2018). Hence, a single bacterium
can produce almost 20 million progeny in a single day (Alberts et al., 2002). Therefore, during
the first critical hours and days of exposure to a new pathogen, animals have to rely on the
mechanisms of innate immunity (Medzhitov and Janeway, 2000), which include antimicrobial
peptides, phagocytes, and the alternative complement pathway. These mechanisms control the
replication of the infecting pathogen while the adaptive response is not ready (Alberts et al.,
2002).
The innate immune response
The innate response, or non-specific immunity is the first natural defense against
pathogens once they have entered the body (Alberts et al., 2002). The innate immune recognition
is mediated by pattern recognition receptors (PRR). Pattern recognition receptors are based on
the detection of molecular structures that are unique to microorganisms and are not present in the
uninfected host. These molecular structures are called pathogen associated molecular patterns
(PAMP, Janeway, 2013). Examples of PAMP include bacterial lipopolysaccharide,
peptidoglycans, lipoteichoic acids, mannans, and glucans (Parham, 2015). Pathogen associated
molecular patterns are produced only by microbial pathogens, not by their hosts (Medzhitov and
Janeway, 2000), allowing the immune cells to discriminate between non-self antigens and selfantigens.
Pattern recognition receptors present in the surface of innate immune cells recognize
PAMPs on the surface of invading microbes (Parham, 2015). Macrophages that reside in tissues
throughout the body where infections are likely to occur (like the lungs, gut, and the mammary
gland) are the first leukocytes to detect pathogens in the tissues (Alberts, 2002). After
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encountering pathogens, macrophages bind to microbial PAMP, promote phagocytosis, and
digest the pathogen into small antigens (Parham, 2015). Additionally, macrophages induce
production of inflammatory cytokines that increase permeability of local blood vessels and
attract other immune cells to the site of infection (Medzhitov and Janeway, 2000).
Cytokines are signaling proteins released by certain cells that affect the behavior of other
cells (Lackie, 2010). Cytokines consist of a diversified group of small peptides synthesized by
cells with the aim of binding to specific receptors on target cells to initiate intra-cellular
signaling cascades (Preshaw and Taylor, 2011). Examples of cytokines include chemokines,
interferons, interleukins (IL), lymphokines, tumour necrosis factors (TNF), and granulocyte
colony stimulating factor (G-CSF) (Zhang and Jianxiong, 2007). Certain cytokines, like IL-β
and TNF-α have inflammatory properties. These inflammatory cytokines cause heat, pain,
redness, and swelling at the site of the infection (Parham 2015), and allow leukocytes, like
neutrophils, monocytes, and NK cells to migrate from blood circulation to the site of the
infection (Zhang, 2007).
Natural killer (NK) cells are another type of lymphocyte that aids in the innate immune
response (Parham 2015). Typically, NK cells do not target a specific antigen. Instead, they target
cells with abnormal behavior, like infected cells and cancer cells (Parham, 2015). On their
surfaces, NK cells have activating and inhibitory receptors that differentiate self-normal cells
from infected and abnormal cells (Alberts, 2002). Natural killer cells destroy virus-infected cells
by inducing the infected cell to kill itself by undergoing apoptosis. Unlike cytotoxic T cells, NK
cells do not express antigen-specific receptors (Parham, 2015).
Another important group of cells that are fundamental to the innate immune response are
granulocytes cells. Eosinophils, basophils, and neutrophils are the three types of granulocytes
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(Parham, 2015). Granulocytes are a group of cells that are characterized by the presence of
granules in their cytoplasm, and these granules are filled with proteolytic enzymes that are used
to digest microbes once they have been phagocytized. Granulocytes are also known as PMN
because their nuclei have an uncommon shape and are divided into different lobules (Alberts,
2002). All granulocytes, or PMN, originate in bone marrow. Eosinophils play an important role
in killing internal parasites. Although these cells have a limited ability to participate in
phagocytosis, they are professional antigen presenting cells (Gleich, 1986). Basophils are the
least abundant granulocyte. However, they are fundamental for the immune system because they
have the capability to travel to the site of the infection and release histamine and prostaglandin
(Kelly et al., 2009). Histamine and prostaglandin increase local inflammation and aid in the fight
against microbes (Kelly et al., 2009). Together with basophils and eosinophils, neutrophils are
part of the PMN cell family. Interestingly, the term PMN often refers specifically to "neutrophil
granulocytes" (Merriam-Webster, 2019), perhaps because neutrophils are not only the most
abundant species of PMN, but also the most abundant type of white blood cells in mammals (60
to 70%) (Parham, 2015).
Elie Metchnikoff first discovered these highly motile phagocytic cells when he inserted
rose thorns into starfish larvae and found that a group of cells accumulated at the puncture site.
Metchnikoff observed phagocytic activity in these cells that he first named “microphagocytes,”
now known as neutrophils (Gordon, 2008). These short-lived cells are very mobile, and have the
ability to enter parts of tissue where other cells cannot (Borregaard, 2010). Just like other
leukocytes, neutrophils’ behavior is dictated by cytokines. Granulocyte-colony stimulating
factors are a group of cytokines that increase production and differentiation of neutrophils by
progenitor cells in the bone marrow (Nomura et al., 1986; Nagata, 1989) After being released
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from the bone marrow; neutrophils circulate in the blood stream for a few hours until they are
attracted to infected tissue by another cytokine, CXCL-8 (Parham, 2015). Neutrophils are the
first-responders and migrate to the site of infection in a process called chemotaxis (Alberts,
2002). While fighting microbes, macrophages will generally survive and continue to patrol
tissues for other pathogens (Segal, 2015), whereas neutrophils die and form pus in acutely
infected wounds (Segal, 2005)
Recombinant G-CSF and the innate immune suppression in dairy cows
In the early postpartum period, bovine neutrophils have been reported to be impaired
(Kehrli et al., 1989; Kehrli and Roth, 1989). Indeed, another study found that blood neutrophils
from early lactation cows had greater rates of apoptosis when compared to neutrophils from midlactation cows (Van Oostveldt et al., 2001) A more recent study has shown that after parturition,
bovine neutrophils can decrease chemotaxis towards the cytokine CXCL8, which can lead to
delayed arrival to the infection site (Graugnard et al., 2012).
Impaired neutrophil function around the time of calving may increase the risk of uterine
and mammary diseases (Bassel and Caswell, 2018). A better understanding of the function of
bovine neutrophils is important to the field of dairy science, as neutrophil manipulation might
represent a novel method of disease prevention which may improve animal health by decreasing
the incidence of production-limiting diseases, like as mastitis and metritis (Bassel and Caswell,
2018).
Granulocyte-colony stimulating factors are a group of cytokines that increase production
and differentiation of neutrophils (Nomura et al., 1986; Nagata, 1989). Generally, the term GCSF refers to the group of signaling proteins that stimulate cell growth, differentiation, survival,
inflammation, and tissue repair. Similarly to other cytokine types, neighboring cells, distant
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tissues and glands, or even tumor cells can secrete them (Nagata, 1989). In humans, the
utilization of commercially available G-CSF in cancer patients is effective in reducing the
incidence of febrile neutropenia (neutrophil numbers below normal values) that typically
happens when chemotherapy is used to treat cancer (Cooper et al., 2011). The utilization of this
artificially produced molecule is only possible because of covalent binding to large polymers,
like polyethylene glycol, that increases the length of activity of these proteins, in a process called
pegylation. Pegylation delays the first-pass renal clearance, and reduces proteolytic degradation
from 3 to 5 hours to 6 to 12 days (Molineux, 2003). Interestingly, a single injection of PEGylated
human G-CSF (pegfilgrastim) provided equivalent efficacy to 11 daily doses of non PEGylated
hG-CSF (Molineux, 2004), which shows the effectiveness of pegylation on increasing the halflife of this molecule by reducing its degradation.
Similarly to other species, bovine neutrophils are produced within the bone marrow,
when G-CSF stimulates the bone marrow to produce granulocytes and stem cells, and subsequent
release of these cells in the bloodstream (Bassel and Caswell, 2018). Neutrophils are formed in 6
days, but are held in the marrow for an additional day (Valli et al. 1971). The G-CSF-receptors
are present in precursor cells in the bone marrow. In response to stimulation by G-CSF,
precursor cells initiate proliferation and differentiation into mature neutrophils (Bassel and
Caswell, 2018).
Pegbovigrastim is an artificial and modified form of the naturally occurring bovine
granulocyte colony-stimulating factor (bG-CSF), produced and commercialized as Imrestor by
Elanco Animal Health (Elanco Animal Health, Greenfield, IN). Mononuclear leukocytes,
endothelial cells, and fibroblasts are responsible for producing the naturally occurring bG-CSF
that is responsible for stimulating the production and increasing activity of granulocyte cells, like
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neutrophils (Avalos, 1996). Pegbovigrastim is identical in the primary sequence to the
endogenously-produced protein, except that it has an additional terminal methionine, a single
amino acid substitution, and a novel amino acid, p-acetylphenylalanine (Figure 1.1). These
changes in the protein structure enable site-specific covalent attachment of a 20 kDa
polyethylene glycol polymer chain. This attachment is responsible for prolonging the activity of
pegbovigrastim from a few hours to a few days, by slowing down its degradation inside the
animal’s body and removal by the kidneys (Harris et al., 2001). Pegbovigrastim is FDA
approved and was commercially available under veterinary prescription. According to the
Imrestor label, when the product is applied subcutaneously 7 days before calving and again at the
day of calving, Imrestor can decrease clinical mastitis incidence by 28% in the first 30 days of
lactation in dairy cows and heifers.
Kimura et al. (2014) explained that treatment with Pegbovigrastim greatly increased
PMN numbers in the circulation of treated cows. After the second Imrestor injection, the PMN
numbers increased by 435% and remained elevated through 13 days after calving when the study
ended. In treated cows, PMN counts peaked on day 1 at 18.99 ± 2.18 million cells/ mL, followed
by a gradual decrease. In the control group, the PMN number remained similar to baseline
measures for −5, −2, and 1 d (4.38 ± 1.13, 4.36 ± 0.9, and 4.32 ± 2.29 million cells/mL,
respectively). The authors theorized that the increase in PMN number should enable more PMN
to travel to an early site of infection, such as the uterus or mammary gland and control the
replication of the infecting pathogen until the adaptive response is ready (Kimura et al., 2014).
In a field study conducted on 17 Mexican dairy herds by Ruiz et al. (2017), Imrestor was
administered to dairy cows approximately 7 days before expected calving and within the first 24
hours after calving. The incidence of clinical mastitis decreased by 25% during the first 30 DIM.
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Moreover, the number of treatments required for mastitis was reduced and consequently less
milk was discarded due to lesser antibiotic use. Surprisingly, clinical metritis incidence
significantly increased by 17.1% when cows were treated with Pegbovigrastim.
To further explore the application of pegbovigrastim under herd management systems
typical of those found in the United States dairy industry, Canning et al. (2017) conducted a
study at four commercial dairies in Wisconsin, Colorado, California, and Washington. In their
study, cows exhibited a 35% decrease in the incidence of clinical mastitis compared to control
cows during the first 30 days of lactation. The authors explained that Pegbovigrastim was well
tolerated by cows and was not associated with changes in milk production or milk composition
(Canning et al., 2017).
Zinicola et al. (2018) evaluated the effects of treating Holstein cows with Pegbovigrastim
on white blood cell count, periparturient diseases, milk production, and reproductive
performance. They found that Imrestor treatment induced postpartum neutrophilia; however, it
did not affect the incidence of mastitis, metritis, puerperal metritis, or clinical endometritis. On
the other hand, when treated with pegbovigrastim, cows were 8.27 times more likely to develop
DA, 1.79 times more likely to have lameness, and 1.39 times more likely to have any clinical
disease during the first 30 days postpartum. Although Pegbovigrastim increased leukocyte
population, the treatment was not accompanied by improvements in the health parameters
measured.
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Table 1.1

A partial list of the metabolic changes associated with lactogenesis in ruminants.

Physiological
Function

Metabolic Change

Tissues involved

Milk Synthesis

Increased use of nutrients

Mammary

Lipid metabolism

Increased lipolysis

Adipose tissue

Decreased lipogenesis
Increased gluconeogenesis

Glucose
metabolism

1

Increased glycogenolysis

Liver

Decreased use of glucose
Increased use of lipids as energy
source

General body tissues

Protein metabolism

Mobilization of protein reserves

Muscle

Mineral metabolism

Increased absorption and
mobilization

Kidney, liver gut and
bone

Adapted from Bauman and Currie (1985)
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Figure 1.1
Pegbovigrastim molecule.
Pegbovigrastim is identical in the primary sequence to the endogenously produced protein,
except that it has an additional terminal methionine, a single amino acid substitution, and a novel
amino acid, p-acetylphenylalanine (Source: Elanco Animal Health)
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CHAPTER II
EVALUATION OF PRODUCTION PARAMETERS AND HEALTH OF DAIRY COWS
TREATED WITH PEGBOVIGRASTIM
Abstract
The aim of this study was to evaluate the effects of pegbovigrastim injection (Imrestor,
Elanco Animal Health, Greenfield, IN) on production parameters and postpartum disease
occurrence (retained placenta, metritis, displaced abomasum, and clinical mastitis) in dairy cows.
Study cows (n = 270) were blocked by parity group (multiparous or primiparous) and randomly
assigned to control (CON, n = 144) or pegbovigrastim treatment (IMR, n = 126). Ten ± 4 d
before expected calving and again at calving, IMR cows received subcutaneous injection
containing 2.7 mL of Imrestor and CON cows received 2.7 mL of 0.9% saline. Milk yield, fat,
protein, lactose, solids nonfat percent, and SCC, body condition, hygiene, and lameness were
evaluated weekly. Animals were evaluated for metritis twice weekly through rectal temperature,
palpation, and uterine discharge evaluation until 30 DIM. Farm personnel recorded other
postpartum diseases. The MIXED procedure of SAS was used to evaluate milk composition and
milk yields were analyzed as repeated measures in time with block, treatment, calving month,
and lactation week included in mixed models. The GLIMMIX procedure was used to evaluate
mastitis and metritis occurrence. Variables entered a model if P ≤ 0.10 when screened
individually. Variables with P ≤ 0.10 were kept in the final model. Milk yield, fat, protein,
lactose, solids-non-fat (SNF), and log of somatic cell count (SCC) were not significantly affected
by treatment. Clinical mastitis occurrence did not differ between treatments, but only 17 cases
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were detected. Although treatment did not increase puerperal metritis occurrence, treated cows
were 2.46 times more likely to develop clinical metritis when compared to control cows. Cows
given pegbovigrastim injections had increased odds of developing clinical signs of metritis, but
no negative effects on milk production and composition were observed.
Keywords: Imrestor, mastitis, metritis
Introduction
The leading cause for involuntarily culling of dairy cows in the United States is udder
and mastitis problems, followed by reproductive disorders (USDA, 2007). More animals are
involuntarily culled in the first 30 DIM than in any other period (Fetrow et al., 2006). Clinical
mastitis in the first 30 DIM costs an average of $444 per case (Rollin et al., 2015).
Environmental and contagious bacteria constantly challenge the mammary gland of dairy cows,
but cows are more susceptible to mastitis after calving (Kimura et al., 1999). Additionally, when
the vulva is relaxed and the cervix is dilated during and after parturition, environment bacteria
can contaminate the uterine lumen, increasing the risk of metritis (Ruder et al., 1981).
Periparturient mastitis and metritis susceptibility in dairy cattle is related to the generalized
immune suppression that occurs from approximately one week pre- to one week postpartum
(Kehrli et al., 1989; Burton et al., 2003).
Polymorphonuclear neutrophils (PMN) are the predominant white blood cell type found
in mammary tissues during acute inflammation, representing 90% or more of total mammary
gland leukocytes during the time of infection (Paape et al., 1979). Unfortunately, white blood
cells are impaired at the time of calving (Kimura et al., 1999) and the ability of PMNs to engulf
and kill bacteria decreases gradually starting around two weeks before expected calving,
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reaching nadir at calving, and slowly increasing two to four weeks after parturition (Kehrli et al.,
1989).
Pegbovigrastim is a modified form of the naturally occurring bovine granulocyte colonystimulating factor (bG-CSF). At the time of the study, pegbovigrastim was commercially
available under veterinary prescription as Imrestor (Elanco Animal Health, Greenfield, Illinois).
According to the product label, when the product is administered 7 days before calving and again
at the day of calving, clinical mastitis (CM) incidence decreases by 28% in the first 30 days of
lactation in dairy cows and heifers. Although some researchers have found a 35% decrease
(Canning et al., 2017) or a 25% decrease (Ruiz et al., 2017) incidence of clinical mastitis when
cows and heifers were treated with Imrestor.
When Imrestor was administered to dairy cows approximately 7 d before expecting
calving and again at calving, the incidence of signs typically associated with clinical metritis
increased by 17.1% when compared to untreated cows, whereas the odds of control cows having
metritis was 16% less (Ruiz et al., 2017). Metritis is a severe inflammatory reaction involving
all layers of the uterus including the endometrial mucosa and submucosa, muscularis, and serosa
(Bondurant, 1999). Clinical signs of metritis include pyrexia, fetid pus within the uterine lumen,
vagina, or discharging from the vulva, and delayed uterine involution (Sheldon et al., 2004). In
contrast to clinical metritis, puerperal metritis is characterized by an acute systemic illness that
often results in fever, reduced milk yield, dullness, inappetence, and anorexia (Sheldon et al.,
2006). Imrestor could potentially affect the number of PMNs called to the uterus post-calving
similarly to what its label claim is for mastitis.
The objective of this study was to test effectiveness of Imrestor at reducing CM
incidence, and to evaluate disease incidence (clinical metritis, retained placenta, displaced
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abomasum) in the first 30 days of lactation on a commercial dairy operation. The hypothesis
tested was that periparturient dairy cattle treated with Imrestor will display difference in disease
incidence. Additionally, production parameters (milk production and components) and SCC
were measured to evaluate differences between Imrestor-treated cows and control cows.
Material and Methods
This randomized controlled trial was conducted on 270 Holstein cows at a commercial
dairy farm in Senatobia, Mississippi from August 7, 2017 to March 31, 2018. The experiment
was designed as a randomized complete block, with two treatment groups and two blocks.
Primiparous cows (n = 98) were all assigned to block one and multiparous (n = 172) were
assigned to block two. Within each block, cows were randomly assigned to one of the two
treatments: Imrestor (IMR, n = 126) or control (CON, n = 144). Animals were randomly
assigned to treatments using the random number generator function within Dairy Comp 305
(Valley Agricultural Software, Tulare, CA). The randomization procedures were repeated
monthly, and the designated treatment assignment was inspected to ensure that the distributions
between the two treatments groups were similar for the predicted 305-day milk production for
multiparous cows. If the 305-day milk production were not similar, the randomization procedure
was redone until similar production across treatments was achieved. Cows were enrolled in the
trial starting on August 7, 2017 until January 31, 2018.
Before the study start, a power analysis was conducted in SAS version 9.4 (Cary, North
Carolina) to estimate the sample size. A mean difference of 1.25 kg of milk/day was tested
because it is the increase in milk a cow would need to produce daily in order pay for the product.
In Mississippi, producers received $17.97/cwt in April 2017 and the product cost
$30/animal/lactation. Previous farm data indicated milk production was normally distributed
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with a standard deviation of 10.35 kg/day. Assuming a power of 0.8 and a type I error associated
with the null hypothesis being 0.05, the necessary amount of animals per treatment was 1061.
To facilitate data collection, each study animal received a leg bend to distinguish them
from non-study animals. In order to avoid possible bias, the second author performed all
randomization procedures but did not participate in on-farm data collection and only shared the
information with the farm manager, who applied the treatments and thus needed to know the
assignments. Farm employees and the other authors did not know which animals belonged to
which treatment at the time of the study.
Anticipated calving dates were determined by farm breeding records. Ten ± 4 days before
expected calving and again within 24 hours after calving, IMR cows received Imrestor (15 mg;
2.7 mL; single pre-filled syringe) and CON cows received saline (2.7 mL of 0.9% of sodium
chloride). Both IMR and saline treatments were given subcutaneously in the neck, using a 3/4” x
18-gauge needle. On a weekly basis, farm personnel gathered animals that were 10 ± 4 days
from their expected calving date and applied treatments. Injections were given on the same day
and approximately the same time each week. Although the product label states that the first IMR
injection should be given 7 days before expected calving, past farm records were evaluated and
the authors expected animals to calve early during hot summer months (June, July, August, and
September). Therefore, 10 days before expected calving was chosen for this study in an attempt
to prevent removing cows from the study due to calving before the first injection was
administered.
Animal husbandry
The Mississippi State Institutional Animal Care and Use Committee (IACUC-17-364)
approved the study protocol. Dry cows were housed in two separate groups based on days in
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gestation: far-off (225 to 262 days of gestation; pasture) and close-up (≥ 263 of gestation;
confinement). Close up cows received TMR consisting of 45% forage and 55% concentrate on a
dry matter basis. The diet was formulated by the farm’s hired dairy nutritionist to meet or exceed
the NRC nutrient requirements for dry Holstein cows weighing 650 kg (NRC 2001).
Farm employees were responsible for checking the close-up barn multiple times per day
to find newborn calves and to help cows with dystocia. They were trained to identify and report
calving scores for each cow at calving, where 1 represented a normal birth without assistance; 2
represented a slight problem with mild human intervention; 3 represented moderate assistance,
requiring introduction of arm into the vagina; 4 represented major assistance, requiring
mechanical extraction; and 5 represented a surgical extraction (Lombard et al., 2007). Farm
personnel relied on experience to determine when interventions were necessary. Calving scores
were recorded in Dairy Comp 305 after each calving. Calves were removed from the maternity
pen immediately after birth and were placed in a straw-bedded pen. Cows were moved to one of
two deep-bedded, sand free-stall barns, primiparous in one and multiparous in another. Lactating
cows were offered ad libitum access to water and TMR consisting of approximately 43% forage
(corn silage) and 57% concentrate (wet brewers grains, soybean meal, ground corn, cottonseed
meal) on a dry matter basis. Cows were fed twice a day, after the morning and the afternoon
milking. Feed was mechanically pushed up three times daily.
Data collection
Once a week, study cows were assigned a score for body condition (BCS), locomotion
(LOC), and hygiene (HYG). These three measurements were collected starting 14 days before
expected calving date to 60 DIM. Body condition was evaluated on a 5-point scoring system,
with quarter point increments, where 1 represented very thin; 2 represented thin; 3 represented
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moderate condition; 4 represented well-conditioned; and 5 represented over-conditioned
(Edmonson et al., 1989). Locomotion score ranged from a 1 to 3, where 1 represented normal
locomotion, no observed difficulty when walking; 2 represented moderately lame, with a slightly
abnormal gait and moderately arched back during the walk, and 3 represented severely lame,
standing and walking with an arched back, with great difficulty walking or moving from lying
position (NAHMS and USDA, 2007). Udder hygiene scores ranged from 0 to 3, where 0
represented no manure present; 1 represented presence of fresh manure in less than 50% of the
rear udder area; 2 represented presence of fresh manure in more than 50% of the rear udder area;
and 3 represented presence of dry caked manure in more than 50% of the rear udder area, as
previously described (Schreiner and Ruegg, 2002).
Composite udder milk samples were obtained for each study cow to assess milk
composition weekly. Automatic milk weights were not available in the parlor so these were also
obtained weekly. These measurements were taken from first sample day milking post-parturition
(1 to 7 DIM) until each cow reached the last week before completing 60 DIM (52 to 59 DIM).
Waikato milk lines (Waikato Milking Systems, Horotiu, New Zealand) were installed in each
milk unit to collect a milk sample and to measure milk yield. Before sampling milk, air was
allowed to enter the system for approximately 10 seconds to allow proper homogenization the
each sample. Samples were placed in a plastic vial containing an 8 mg tablet of bronopol (2bromo-2-nitropropano-1, 3-diol) utilized to delay microbial growth. Samples were kept over the
weekend at room temperature until they were sent to Mid-South Dairy Records (Springfield,
MO) for analysis of fat, protein, lactose, solids non-fat (SNF) (%), and SCC (cells/ml).
Each morning, before attaching the milking units, milkers forestripped each quarter of
each cow and observed the general milk and udder appearance. Before the study started, all 7
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milkers were trained to identify and score clinical mastitis using a scale from 1 to 3 (Table 1).
This information was recorded for each clinical case until cows reached 60 DIM.
During their first 30 DIM, study cows were palpated twice a week to evaluate clinical
metritis status. The farm visits were scheduled so that the veterinarian of record (VOR) visited
the farm at least once every two weeks. A palpation chart was developed by the VOR (Table 2)
based on clinical experience, and the graduate student managing this project was trained to
perform the health checks by the VOR. In the absence of the VOR (every other week), the
graduate student performed the health evaluations. In each health check, uterine tone and vaginal
discharge were evaluated. Presence of watery, reddish-brown or white and purulent, fetid odor
discharge was used to define clinical metritis. In addition, rectal temperature (RT) and rectal
palpation of the uterus were performed to aid in puerperal metritis recognition (Sheldon et al.,
2006). Presence of abnormal discharge along with fever (RT above 40℃ over summer and fall,
or 39.7 ℃ during winter) were the cut points for puerperal metritis.
Results and discussion
The intervals between the first dose of Imrestor and actual calving date are displayed in
Figure 1. On average, cows received the injection 8.46 ± 5.24 days before calving, with a range
of 27 days. A total of 52 cows (19.26%) received their second injection within 0 to 3 days after
the first injection; 132 (49.63%) received their second injections 4 to 10 days after their first
injection; and 84 cows (31.1%) received their second injection more than 10 days after they
received their first.

44

Effect of IMR in milk production and SCC
The model to determine milk yield in CTL and IMR cows accounted for effects of block
(P < 0.01), lactation week (P < 0.01), and calving month (P = 0.04) (Table 3). Treatment and
block did not interact to affect MY (P = 0.30); therefore, the interaction effect was excluded from
the final model. The effect of block was significant, and milk production was decreased in
primiparous cows compared to multiparous cows (36.87 ± 0.91 and 44.67 ± 0.69 kg,
respectively). Treatment was not associated with a change in MY (P = 0.62). These results are in
agreement with previous research that also did not detect change in MY in the first 30 DIM when
cows were treated with Imrestor or a sterile saline control (Canning et al., 2017). As expected,
milk production increased over the 8 weeks following parturition (Figure 2). Effect of calving
month was also significant (P < 0.01). Cows that calved in the summer months had lesses milk
production compared to cows that calved in winter months (August with 37.85 ± 1.65 kg;
September 39.35 ± 1.38; October 38.45 ± 1.11 kg; November 38.98 ± 1.21 kg; December 40.55
± 1.60 kg; January 43.57 ± 1.69 kg).
The model to determine SCC in CTL and IMR cows accounted for block (P = 0.87) and
lactation week (P < 0.01). Weekly mean SCC in the first eight weeks of lactation is shown in
Figure 3. No significant differences in the log of SCC on CON and IMR cows were observed (P
= 0.21). These results indicate that despite the pronounced increase in the number of circulating
neutrophils in the blood typically observed following pegbovigrastim-treatment (Kimura et al.,
2014; Zinicola et al., 2018), SCC does not increase in the milk. These results are of great
importance given the important role of milk SCC in assessing milk quality. Furthermore, these
results are consistent with the findings of Canning et al. (2017), who observed no significant
differences in SCC between IMR and saline treated cows.
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Animals treated with IMR also produced milk with similar composition to the salinetreated CTL, milk fat, protein, lactose, and SNF percentages did not significantly differ (P =
0.35, 0.24, 0.48, and 0.34, respectively; Table 2 and Figure 4). Effect of block (P < 0.01, 0.01,
0.01, and 0.61), lactation week (P < 0.01, 0.01, 0.01, and 0.01), and calving month (P < 0.01,
0.01, 0.01, and 0.01) were included in the fat, protein, lactose, and SNF models.
Overall, the results found in the present study are in accordance with results found in
previous studies, where no significant changes were observed in MY, components, and SCC
between pegbovigrastim-treated cows with non-treated cows (Ruiz et al., 2017) or placebotreated controls (Hassfurther et al., 2015; Canning et al., 2017). These results indicate consistent
proof that pegbovigrastim treatment is capable of enhancing neutrophil activity without
negatively impacting performance of dairy cows.
Effects of pegbovigrastim on disease occurrence
The frequency and percent of clinical disease(s) within study cows is shown in Table 4.
Clinical metritis occurred often in both treatment groups and very few cows had one disease by
itself not accompanied by clinical metritis. While deciphering if treatment altered fresh cow
disease, a new variable combining all fresh cow disease (including displaced abomasum, retained
placenta, and mastitis) were created.
Administration of pegbovigrastim has been associated with decreased CM incidence, but
no significant difference was observed between the IMR and CTL groups in the present study (P
= 0.54). However, CM occurrence was infrequent in both treatments. Of the 270 cows in the
study, only 17 CM cases were detected (10 IMR cows and 7 CON cows), corresponding to only
6.41% of all study cows. These results are in conflict with a previous study conducted in
different regions of the U.S. (Wisconsin, Washington, Colorado, and California), where
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researchers reported that cows that received pegbovigrastim exhibited an average decrease of
35% in the incidence of CM (P < 0.01, 122 detected cases of CM) relative to the controls during
the first 30 days of lactation (Canning et al., 2017). Additionally, in a multi-site study conducted
in Mexico, Imrestor reduced the incidence of mastitis by 25% (P < 0.01, 442 detected cases of
CM), whereas the odds ratio of developing mastitis in the first 30 DIM were 35% greater for
control cows than for Imrestor cows (P < 0.05) (Ruiz et al., 2017). Nevertheless, these results are
similar to a study that was conducted in New York, where IMR treatment did not affect CM
occurrence (P = 0.18) (Zinicola et al., 2018). In this recent study, the reported incidence of CM
in the control group was 4.26% (n = 423), similar to the 4.86% found in the present study.
Therefore, in these two studies, IMR treatment did not prevent mastitis. Zinicola et al. (2019)
reported numerically more CM in the IMR group than in the CTL group, in concurrence with
this study. Interestingly, although IMR treatment increases circulating levels of neutrophils,
recent studies have reported that the neutrophil phagocytic activity, oxidation burst, and
myeloperoxidase function is not altered by IMR treatment (Kimura et al., 2014; McDougall et
al., 2017). Hence, it is possible that the prevention of CM is also related to activity of neutrophils
rather than an increase in neutrophil number. Additionally, IMR treatment did not affect
displaced abomasum, and combination of diseases (P = 0.16 and 0.12). Imrestor treated cows
tended to have greater retained placenta (P = 0.09).
The frequency and percentage of different uterine scores and occurrence of clinical
metritis is presented in Table 5. Statistically, IMR treated cows displayed decreased incidence of
uterine score 0 (CON = 40 and IMR = 16) and increased occurrence of uterine score 2 (CON =
46 and IMR = 62). The final model to predict clinical metritis occurrence contained effects
treatment (P < 0.01) and block (P = 0.69). Imrestor cows had a 25% greater incidence of clinical
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signs of metritis (P < 0.01) and were 2.46 more likely to develop the disease (P < 0.01, with a
95% confidence interval ranging from 1.41 to 4.31, Table 6). The increase in clinical metritis
occurrence in this study is in agreement with Ruiz et al. (2017), who observed that
administration of pegbovigrastim resulted in greater incidence of metritis (17.6%) and greater
odds (16.4%) of developing metritis in the first 21 days after calving (P = 0.01).
Most dairy cattle are affected by bacterial contamination in the uterus following calving
(LeBlanc et al., 2011). Therefore, it is logical that an innate immune response following
contamination will occur. A rise in PMN numbers following IMR administration would likely
lead to the development of more purulent discharge, increasing the detectability of clinical
metritis. In this study, metritis status was evaluated twice a week via rectal palpation of the
uterus and visual observations of uterine discharges. When consistently looking for a disease,
one is more likely to find it. Therefore, the VOR and graduate student could have detected even
mild cases of clinical metritis. Sheldon et al. (2006) reported general clinical metritis incidence
of 25 to 40%, which is less than the 46.5% found in this trial.
Conclusion
The first objective of this study was to test effectiveness of Imrestor at reducing CM
incidence. There was no effect of treatment on CM. Additionally, no negative effects on milk
production or components were observed between treatments. The second objective was to
evaluate disease incidence (clinical metritis, retained placenta, displaced abomasum) in the first
30 days of lactation. The hypothesis tested was that periparturient dairy cattle treated with
Imrestor will display differences in disease incidence. Cows given pegbovigrastim injections
around the time of calving had increased odds of developing clinical signs of metritis, although
occurrence of puerperal metritis did not significantly increase. The increased odds of developing
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clinical signs of metritis in IMR cows is concerning and should be studied in more detail to
understand this relationship.
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Table 2.1

Clinical mastitis scoring system: cows exhibiting abnormal quarter, milk or a
combination of both were recorded

Clinical

Appearance of
Appearance of milk

Appearance of quarter

score

0

the cow

Normal

Normal

Normal

Normal

Normal

Abnormal (flakes,
1
clots, or discoloration)

2

3

Abnormal (obvious

Abnormal (sights of

flakes, clots, or

inflammation/swelling,

discoloration)

worm to touch)

Abnormal (obvious

Abnormal (sights of

Abnormal

flakes, clots, or

inflammation/swelling,

(lethargic, sick

discoloration)

worm to touch)

looking)
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Normal

Table 2.2

Clinical metritis scoring system used to evaluate disease status in cows treated
with Imrestor or saline on a commercial Mississippi herd
Clinical
Uterine condition
score1
Uterus is in adequate size and tone, and clean discharge
0
relative to DIM
Poor tone, flaccid, no ruggae formation, presence of fluid after
1
14 DIM
Abnormal discharge (watery reddish-brown or white and
2
purulent, fetid odor)
Presence of abnormal discharge and fever (rectal temperature
3
> 40℃ over the summer or 37.7 ℃ during fall and winter2)

1

0 to 5 DIM: Ruggae should develop on palpation of uterus, with clear increase in tone when
palpated via rectum, with thick, viscous, clear, straw-colored discharge; 6 to 13 DIM: Tone is
smooth leathery, it should return to normal position upon pinch. Discharge is be thick viscous,
more likely to be clear, straw-colored, red tinge; 14 DIM: Both horns are palpable with no fluid
present in the uterus; 15 to 30: Muscular tone, with no discharge.
2
Fever cut point was switched in December 22nd.
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Table 2.3

Mean of production parameters, somatic cell account, general scores, and average rectal temperature in cows treated
with Imrestor or saline on a commercial Mississippi herd. Effects of block, month of calving, lactation week and
injection interval were accounted for in models unless noted otherwise.
Variable
Milk yield (kg)
Energy corrected milk (kg)
Fat (%)
Protein (%)
Lactose (%)
SNF (%)
Log of SCC
Fat (kg)
Protein (kg)
Lactose (kg)
Body condition score
Walking score
Hygiene score
Rectal temperature (°C)4

Treatment
CTL
IMR
41.04 40.54
38.23 37.45
3.67
3.61
2.95
2.97
4.95
4.95
8.85
8.87
2.71
2.77
1.50
1.46
1.20
1.18
2.02
2.01
2.85
2.89
1.21
1.14
0.29
0.28
39.01 38.96

Treatment
0.67
0.49
0.34
0.49
0.88
0.61
0.34
0.37
0.73
0.82
0.38
0.07
0.86
0.10

1

Block
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
0.59
0.84
< 0.01
< 0.01
< 0.01
<0.01
<0.01
0.07
< 0.01

P-value
Month Fresh1
0.02
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
NS5
< 0.01
NS
0.06
<0.01
0.04
NS5
< 0.01

LW2
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
0.04
0.54
< 0.01

Injection Interval3
0.08
0.10
0.40
0.11
0.24
0.21
0.78
0.19
0.05
0.03
0.56
0.74
0.37
0.19

Month of calving (ranging from August, 2017 to January, 2018)
Lactation week (ranging from week one until week eight after calving)
3
Injection interval (0 = shot interval from 0 to 3 days, short interval; 1 = shot interval from 4 to 10 days; 2 shot interval greater than
10 days)
4
Significant interaction between block and lactation week (P < 0.01)
5
No significance observed (P > 0.05), effect not included in model.
2
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Table 2.4

Frequency and percentage of clinical diseases on cows treated with Imrestor or
saline on commercial Mississippi herd.
Control

Imrestor

Disease

Number

Percent

Number

Percent

P-

incidence

of study

of study

of study

of study

value

cows

cows

cows

cows

7

4.9

10

7.9

0.44

4

2.8

14

11.1

0.09

1

0.7

4

3.2

0.16

12

8.3

26

20.6

0.12

Clinical
mastitis
Retained
placenta
Displaced
abomasum
Combination
1

Normal uterus; no metritis.
Poor uterine tone; no metritis.
3
Metritis.
4
Metritis and fever.
2
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Table 2.5

Frequency and percentage of clinical metritis occurrence by category in study
cows treated with Imrestor or saline on a commercial Mississippi herd.
Treatment
Uterine

PControl

Imrestor

Score1

value
Frequency

Percent

Frequency

Percent

0

40

28.7

16

13.11

0.02

1

47

33.1

36

29.51

0.28

2

46

32.39

62

50.82

0.03

3

9

6.34

8

6.56

0.84
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Table 2.6

Point estimate, standard error, P-values, and confidence intervals associated with
metritis occurrence in dairy cows that were treated with Imrestor or saline on a
commercial Mississippi herd.
Estimate2

SE

P-value

95% CI3

Control

Ref.

-

-

-

Pegbovigrastim

2.46

0.65

< 0.01

1.41 to 4.31

Primiparous

Ref.

-

-

-

Multiparous

1.65

0.82

0.69

0.13 to 20.72

Parameter
Treatment

Parity

1

Clinical metritis cut point was the presence of abnormal, watery reddish-brown or white and
purulent, and fetid odor discharge
2
Point estimate of odds ratio for developing metritis;
3
Confidence interval;
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25

Frequency

Cumulative

100%

Frequency (amount of animals)

90%
20

80%
70%

15

60%
50%

10

40%
30%

5

20%
10%

0

0%
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 23 24 25 26 27

Injection interval (days)
Figure 2.1

Days from first subcutaneous administration of Imrestor (Elanco Animal Health,
Grenenfild, IN) to calving (mean ± SD = 8.46 ± 54.24 range = 0 to 27)
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MILK YIELD (KG)

46.0

Control

44.0

Imrestor
42.0

40.0
38.0
36.0
34.0

1

Figure 2.2

2

3

4
5
Lactation week

6

7

8

Effect of Imrestor on milk (mean ± SE kg) in the first 8 weeks of lactation of
Holstein cows treated with Imrestor or saline control (milk yield measured
weekly).
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4.00
Control

FAT %

3.85

Imrestor

3.70
3.55
3.40
1

Figure 2.3

2

3
4
5
Lactation week

6

7

8

Effect of Imrestor on fat in milk (mean ± SE %) in the first 8 weeks of lactation of
Holstein cows treated with Imrestor or saline control (milk fat measured weekly).
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3.35
Control
Imrestor

PROTEIN (%)

3.20
3.05
2.90
2.75
1

Figure 2.4

2

3

4
5
Lactation week

6

7

8

Effect of Imrestor on protein in milk (mean ± SE %) in the first 8 weeks of
lactation of Holstein cows treated with Imrestor or saline control (milk fat
measured weekly).
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5.00
Control

LACTOSE (%)

4.95

Imrestor

4.90
4.85
4.80
1

Figure 2.5

2

3

4
5
Lactation week

6

7

8

Effects of Imrestor on lactose in milk (mean ± SE %) in the first 8 weeks of
lactation of Holstein cows treated with Imrestor or saline control (milk fat
measured weekly).
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9.07
Control

SNF (%)

8.97

Imrestor

8.87
8.77
8.67
1

Figure 2.6

2

3

4
5
Lactation week

6

7

8

Effect of Imrestor on lactose in milk (mean ± SE %) in the first 8 weeks of
lactation of Holstein cows treated with Imrestor or saline control (milk fat
measured weekly).
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CHAPTER III
EVALUATION OF REPRODUCTION AND BEHAVIOR PF DAIRY COWS TREATED
WITH PEGBOVIGRSTIM
Abstract
The aim of this study was to evaluate the effects of pegbovigrastim injection (Imrestor,
Elanco Animal Health, Greenfield, IN) on behavior and time to first detected heat. The study was
conducted on a commercial Mississippi dairy from August 21, 2017 to March 31, 2018. Initially,
a total of 270 cows were blocked by parity group (multiparous or primiparous) and randomly
assigned to control (CON, n = 144) or treatment (IMR, n = 126). Study animals were equipped
with smart leg and smart neck tags (Nedap, the Netherlands). Ten ± 2 d before expected calving
and again at calving, treated cows received 2.7 mL of Imrestor and CON cows received 2.7 mL
of 0.9% saline. Cows were body condition (BCS), hygiene (HYG), and lameness (LAM) scored
weekly. The Nedap system created heat alerts based in individual behavior changes. Weekly
summations of number of steps, time spent lying down and walking (min) was then utilized to
determine weekly means of these variables since calving until 60 DIM. Unfortunately, because
of malfunction in the data synch between tags and the farm software, data from only 61 cows
were utilized in the analysis (CON = 43 and IMR = 18). The MIXED procedure of SAS was
utilized to compare the leg activity, walking time, and lying time between the two treatment
groups. The mixed models included fixed effects of treatments and block, and random effect of
cow within block. A Cox proportional hazards regression was used to determine the relative
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likelihood of cows displaying estrus within their first 60 DIM. Imrestor treatment did not alter
the hazard ratio of estrus occurrence during the first 60 DIM (hazard ratio = 0.99, 95% CI = 0.84
to 1.7, P = 0.88). The median calving-to-first detected heat interval for IMR and CTR cows was
47 and 46 d, respectively (P = 0.45). Imrestor treatment did not affect time spent lying, walking,
or amount of steps given (P = 0.54, 0.59, and 0.48, respectively). In conclusion, IMR treatment
did not affect the behavior or time to first detected heat in study cows.
Introduction
Heat detection is critical to breeding programs; particularly artificial insemination and
embryo transfer programs. The most accurate sign of estrus is when a cow is standing to be
mounted, although secondary signs like mounting other cows, vaginal mucus discharge, swelling
of the vulva, and restlessness can also aid in estrus detection (Allrich, 1993).
Mean yearly estrus detection rate in U.S. Holstein herds is reported to be 44.9% in 2015
(DRMS, 2015). This low estrus detection rate may be a consequence of the great decline in the
duration of estrus in Holstein cattle, from 18 to less than 8 hours, over the past 50 years (Reames
et al., 2011). Additionally, estrus assessments are subjective, time consuming, and accompanied
by wide variation of external signs among dairy cows that requires practice and expertise by the
human observer (Senger, 1994).
Potential advantages of precision dairy monitoring technologies include increased
efficiency, early detection of disease with consequent reduced disease costs, and improved
animal well-being. Parameters monitored by these technologies include daily milk yield, milk
components, behavior (number of steps given, lying, walking, eating, and ruminating time),
temperature (in various places on and in the cow like rumen and ears), milk conductivity, daily
body weight, rumen pH, blood or milk progesterone levels, and others (Bewley, 2010). All these
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parameters can also be utilized to detect estrus activity in cows and determine adequate time of
insemination (Dolecheck et al., 2015).
On top of these advantages, technologies provide new opportunities to examine animals
without observer interference. In turn, they can be used to gain an increased understanding of
physiological and management factors that influence dairy cattle behavior. Behavioral
observations of animals that are treated with novel products, such as Imrestor (IMR, Elanco
Animal Health, Greenville, IN), can provide further evidence of the effectiveness of the product
or could potentially explain hurdles that must be overcome in order for the product to be
effective.
Pegbovigrastim, the main component of IMR, is a modified form of the naturally
occurring bovine granulocyte colony-stimulating factor. When administered at the time of
calving, this protein is capable of increasing the number and activity of polymorphonuclear
neutrophil (PMN) (Kimura, 2014). Because of the immune modulating effect caused by IMR,
decreased clinical mastitis incidence was reported to decrease by 35% in the first 30 days of
lactation in dairy cows and heifers (Canning, 2017).
The objective of this study was to test the effectiveness of IMR-treated cows in returning
to their normal uterine function, assessed by days to first detected heat. Periparturient dairy cows
from a commercial dairy herd in Mississippi treated IMR were expected to be more equipped to
counteract natural infection with metritis pathogens due to heightened function of the innate
immune system. They were thus expected to display greater days to first detected heat when
compared to placebo-treated cows. This hypothesis arose because past studies have found that
IMR-treated cows displayed a significant increase in metritis incidence (17.1%; Ruiz et al.,
2017). Further objectives of interest were to assess some behavioral parameters (time spent lying
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down, walking, and number of steps) that are used to identify estrus, and compare them between
IMR- and CON-treated cows.
Material and methods
This study was conducted on 270 Holstein cows at a commercial dairy farm in Senatobia,
Mississippi, from August 7th, 2017 to March 31st, 2018. The study was designed as a
randomized complete block, with two treatment groups and two blocks. Primiparous cows (n =
98) were all assigned to block one, and multiparous (n = 172) were assigned to the second block.
Within each block, cows were randomly assigned to one of the two treatments: IMR (n =
126) or control (CON, n = 144). The randomization procedure was done in Dairy Comp 305
(Valley Agricultural Software, Tulare, CA). The randomization procedures were repeated
monthly, and designated treatment assignment was inspected to ensure that the distributions
between the two treatments groups were similar for the predicted 305-day milk production for
multiparous cows each month. If the 305-day milk production were not similar, the
randomization procedure was redone until similar production across treatments was achieved.
Cows were enrolled in the trial during multiple months of the experimental period (starting on
August 7, 2017 until January 31, 2018). Hence, animals calved and joined the trial in different
seasons of the year (total of 32 weeks).
Ten ± 4 days before expected calving and again within 24 hours after calving, treated
cows received Imrestor (15 mg; 2.7 mL; single pre-filled syringe) and control cows received
saline (2.7 mL of 0.9% of sodium chloride). Anticipated calving dates were determined by farm
breeding records. On a weekly basis, farm personnel gathered animals that were 10 ± 4 days
from expected calving date to apply the treatments. Injections were given on the same day and
time each week. Both treatments were given subcutaneously in the neck, using a 3/4” x 18-gauge
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needle. A total of 24 cows calved more than 14 days before their expected calving date, and
never joined the trial because they never received their first injection.
In the same day of the first injection date, a neck tag and a leg tag, each with activity
monitoring sensors (Nedap Livestock Management, Groenlo, the Netherlands) was attached to
the neck and hind left leg of each study animal. Neck tags were positioned loosely on each cow’s
neck so that a sideways hand’s width could fit between the cow’s neck and the strap, in
accordance with manufacturer’s instructions. The leg tags were placed tightly enough to avoid
them falling below the dewclaws, but not tight enough that the cow was unable to comfortably
move, also in accordance with manufacturer’s instructions.
Technology management
The Nedap COWcontrol ™ system (Nedap Livestock Management, Groenlo, The
Netherlands) is composed by the leg, and neck tags together with a process controller, that
receives the data from each tag and uploads it on the Nedap Velos System. The farm contained
two processes controllers, one by the milking room, and close to the lactation pens, and the
second by the dry-cow barn.
The leg tag measured lying time, standing time, and activity with a three-axis
accelerometer (on a 15 minutes basis). The neck tag measured time spent ruminating, eating,
inactive, or other activity (in seconds).
There was not a fixed threshold for the creation of heat alerts, because every cow is not
equally active. Instead, variation in the normal activity of individual animals was utilized to
generate alerts. The system automatically calculates alerts by dividing a day in periods of two
hours, and in two-hour-period, each cow activity is measured. The mean and the standard
deviation (SD) of the same two-hour-period in the previous 10 days are defined. Then, the
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activity of a certain period minus this mean, is divided by the previously mentioned SD, the
outcome is the increase factor. There is an increased activity during this period if the increase
factor is > 1.5. A heat attention (recorded as a 1 in the dataset) is given if the increase factor is >
1.5 for three consecutive two-hour-periods and if the mean of the increase factor of these three
periods is > 3.0. A suspicious attention (recorded as a 2 in the dataset) is given if the increase
factor is > 1.5 for two consecutive periods. According to Nedap, the latter is a more sensitive but
a less specific method; therefore, only heat attentions (recorded as a 1 in the dataset) were
utilized in this study.
Farm personnel were responsible for visually checking technologies on a weekly basis,
and adjusting the tags if they were too loose or tight. Lost tags were recovered and placed back
on the same animal.
Because the amount of tags supplied were not enough to assign tags on all enrolled cows
for the duration of the study period, tags were removed from study cows and reassigned to new
study cows entering the pre-fresh period as needed. The removed tags were reassigned and
attached to other study cows ≥ 14 days prior to expected calving.
Data Collection
Once a week, study cows were assigned a score for body condition (BCS), locomotion
(LOC), and hygiene (HYG). These three measurements were taken starting 14 days before the
expected calving date until cows reached 60 DIM. Body condition was evaluated on a 5-point
scoring system, with quarter point increments, where 1 = very thin; 2 = thin; 3 = moderate; 4 =
well conditioned; and 5 = over-conditioned. The areas of interest for evaluation of quarter point
increments were hooks, pins, point of thurl, tailhead ligaments, and sacral ligaments as proposed
by Wildman et al., 1982.
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Locomotion score ranged from a 1 to 3, where 1 represented normal locomotion, no
observed difficulty when walking, and all feet placing the floor purposely; 2 represented
moderately lame, with a slightly abnormal gait and moderately arched back during the walk, and
3 represented severely lame, standing and walking with an arched back, with great difficulty
when walking or moving from lying position.
Udder hygiene scores ranged from 0 to 3, where 0 represented no manure present; 1
represented presence of fresh manure in less than 50% of the rear udder area; 2 represented
presence of fresh manure in more than 50% of the rear udder area; and 3 represented presence of
dry caked manure in more than 50% of the rear udder area.
Milk yield was recorded and milk samples were obtained to assess composition for each
cow’s milk weekly. These measurements were taken from first sample day milking postparturition (1 to 7 DIM) until each cow reached the last week before completing 60 DIM (52 to
59 DIM).
These measurements were digitized on a weekly basis this information was later utilized
to generate possible covariables for the statistical models.

Data editing
Nedap made weekly behavior data available on the cloud content platform Box (Box,
Inc., Redwood City, CA). The data was provided in Microsoft Excel format (Microsoft
Corporation, Redmond, WA). At the end of the study, all data were merged into single files.
Data from each tag were downloaded and imported into Microsoft Excel. The 15-minute data
were summed into weekly totals from calving until 60 DIM (approximately 8 weeks). Weekly
summations of number of steps, time spent lying down and walking (min) was then utilized to
determine weekly means. Weekly summations and means were imported into SAS (Cary NC,
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USA) for further analysis. Due to altered activity around calving time, pre-calving data from
each study cow was excluded from the analysis to avoid bias. Additionally, since in this study
cows were only studied up to their 60 DIM, any data collected after that point was also excluded.
A total of 270 animals were enrolled in the study, but data from only 61 cows were
utilized in the final analysis. Unfortunately, the amount of tags acquired was not enough to
employ tags on all enrolled cows for the duration of the study, so tags needed to be removed
from study cows they reached 60 DIM. Researchers and farm staff kept detailed records of when
tags were moved to a new cow and updated the Velos system accordingly. However, the tags did
not always update to associate the data to the new cow even though they were updated on the
authors’ end. The integration from DairyComp and the processing unit might have caused issues,
and the synch from DairyComp and Velos did not work properly; therefore, the connection
between animal and tag did not present in the processing unit, and any data from tag was lost,
since there was no animal to connect to. This system failure was not recognized until the data
was analyzed because the tags were still functioning according to the Velos system, which was
checked each day to ensure that no tags had failed. As a result of the missing data, out of a total
of 32 weeks (whole duration of the study), only data from the first 12 weeks of the study were
analyzed.

Statistical Analyses
The MIXED procedure of SAS was utilized to analyze leg activity, walking time, and
lying time. The LSMEANS statement was used to determine: 1) average time spent walking
(min/wk); 2) average time spent lying down (min/wk); and 3) amount of steps given (average
amount of steps/wk). All mixed models included fixed effects of treatments and block, and
random effect of cow within block. Other variables of interest, like BCS, LOC, and HYG,
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disease incidence, and milk yield and components, were tested in each model as possible
covariables; however, only variables with P < 0.10 were utilized on final models. Two-way
interactions were tested in each model; however, only significant interactions (P ≤ 0.10) were
kept in the model.
The PHREG procedure was utilized to perform the Cox proportional hazards regression
to determine the relative likelihood of cows displaying estrus within their first 60 DIM. In this
analysis, effect of treatment, block, and month of calving were used as fixed effects.
Additionally, the LIFESTEST procedure was used to assess treatment effects of treatment on
estrus detection. The censoring variable was set to 1 to describe animals that showed the event
under investigation (estrus). The log-rank and Wilcoxon test was used to determine treatment
effect.
Results and discussion
Time to first detected heat
Due to the mode of action of IMR, the increased number and activity of PMN could lead
to more animals exhibiting clinically apparent inflammation and displaying more abnormal
discharge (thick, white, purulent, and fetid odor), consequently increasing metritis detection
(Oliveira, 2018). In the present study, IMR cows had greater incidence of metritis (25%
increase, P < 0.01), and were 2.21 more likely to develop the disease (P < 0.01, with a 95%
confidence interval ranging from 1.31 to 3.76, results displayed in first part one of this report).
Nevertheless, it is possible that despite the increased incidence of metritis, the uterine function
could return to cyclicity without delaying the time to first detected heat.
Imrestor treatment did not alter (P = 0.88) the hazard ratio of estrus occurrence during the
first 60 DIM (hazard ratio = 0.99, 95% CI = 0.84 to 1.7; Table 1 and Figure 1) of cows. The
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median calving-to-first detected heat interval for IMR and CTR cows was 47 and 46 d,
respectively (P = 0.45). Interaction between block and treatment was not added to the final
model due to lack of significance (P > 0.10). This findings are in agreement with Zincola et al.
(2018), who found that Imrestor treatment did not alter (P = 0.66) the hazard of cows being
inseminated within the first 120 DIM (hazard ratio = 1.03, 95% CI = 0.89 to 1.19).
Due to the reduced amount of animals that contributed to these results, more studies, with
larger sample size, would be ideal to evaluate whether IMR treatment has the potential to affect
day to first heat in dairy cows.

Lying behavior
Imrestor treatment did not affect time spend lying (P = 0.59, Table 1). On average, IMR
cows and CON cows spent 87.3 and 88.4 hours/wk lying down (12.5 and 12.6 hours/d,
respectively). The time spent lying down for both treatment groups is consistent with previous
research that have found that dairy cows kept in free-stall barns should spend, in average, 11 to
14 hours lying down (Haley et al., 2000).
The effect of block was highly significant in this model (P < 0.01), and multiparous cows spent
more lying down then primiparous. No interaction between treatments and block were observed
(P > 0.05), therefore the effect of that interaction was not accounted in this model. Additionally,
within all variables tested in this model, only lameness score met the criteria to be added to final
model (P = 0.08).
Lying is considered to be higher priority than eating when opportunities to perform these
behaviors are restricted (Munksgaard et al., 2005). Adequate lying and resting time is positively
associated with productivity, health, and welfare of dairy cattle (Cooper et al., 2008); on the
other hand, decreased lying has been associated with pain, and with risk of becoming ill (Weary
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et al., 2009). Therefore, the results found in the present study suggest the IMR treatment is not
associated with negative consequences in the lying behavior and welfare or dairy cows. To the
best of the authors’ knowledge, no other study has evaluated the differences in lying behavior
between IMR and CON cows.

Leg activity
Imrestor did not significantly change the amount of steps given by cows; neither the time
spent walking (P = 0.48 and 0.59, respectively). These results indicate that the increase in
neutrophil numbers and neutrophil activity, typically observed in IMR treated cows, may not be
associated with changes in activity of dairy cows in their first 60 DIM.
If IMR treatment were to negatively change the natural behavior of cows (e.g. to reduce
their lying time), production parameters could also be affected as a consequence. Additionally, a
potential negative public perception of the product could arise, ultimately leading to a negative
image of the treatment. Fortunately, that was not the case with IMR treatment.
The effect of block was highly significant in these two models (P < 0.01), and
primiparous cows spent more time walking, and consequently, also gave more steps on average
week basis. These results are in agreement with previous research that have observed that
primiparous cows spent more time feeding, visited the feed bunk more frequently, lay down
more frequently, although spend less time lying when older multiparous cows (Naeve et. al.,
2017). No interaction between treatments and block were observed (P > 0.05), therefore effects
of interactions were not accounted in any model.
Diseased animals often exhibit abnormal or reduced activity (Proudfoot et al., 2009);
therefore, changes in the walking behavior and number steps given are potential indicators and
predictors of health issues such as postpartum disorders (metritis and retained placenta;
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Sepúlveda-Varas et al., 2014). However, although IMR treated cows displayed increased metritis
incidence, no differences in behavior were detected in this study.
Although IMR cows displayed increased occurrence of metritis in their first 30 DIM, no
differences were observed in time to first detected heat; suggesting that increased metritis
occurrence was not associated with decreased reproductive status. Additionally, despite the
increase in metritis occurrence, no difference in lying behavior was detected. In conclusion, the
utilization of novel products in farm animals has the capability of affecting consumer concerns
due to the possible change on health and well-being of farm animals, especially if their natural
behavior is changed. However, the results found here indicate that IMR treatment, either via the
expected physiological change in the immune system or other potential pathways following IMR
treatment, is not associated with significant changes in behavior of dairy cows.
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Table 3.1

Point estimate, standard error, P-value, and hazard ratio associated with heat
detection occurrence in dairy cows on their first 60 DIM
Parameter
Parameter

Hazard
SE

P-value

Estimate

Ratio

Treatment
Control

Ref.

-

-

-

Pegbovigrastim

-0.13

0.009

0.15

0.88

Primiparous

Ref.

-

-

-

Multiparous

0.12

0.009

< 0.01

1.13

Parity

Place all detailed caption, notes, reference, legend information, etc here
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Table 3.2

Walking time, lying time, and leg activity (means ± SEM) of different age cows
treated with Imrestor or saline on a commercial Mississippi herd1
Treatment

P-value

PP-value

Variable

value
Control

Imrestor

Lameness

1

Treatment
Block

Walking time

369.33 ±

378.23 ±

11.85

16.59

Lying Time

5,304 ±

5,238 ±

(minutes/week)

212.16

296.4

31,931 ±

32,769 ±

(minutes/week)

Leg activity
(steps/week)
1

855

0.08

0.59

< 0.01

NS

0.54

< 0.01

0.02

0.48

< 0.01

1,198

Lameness score was utilized as a covariate in models if P > 0.10.
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Figure 3.1

Effect of Imrestor on time to first detected heat in the first nine weeks of lactation
of Holstein cows treated with Imrestor (blue) or saline control (red).

78

Leg activity (Steps/wk)

Control

Imrestor

49,000
44,000
39,000
34,000
29,000
24,000
1

2

3

4

5

6

7

8
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Imrestor

49,000
44,000
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34,000
29,000
24,000
1

2

3

4

5

6

Lactation week

Figure 3.2

Effect of Imrestor on leg activity and walking time (mean ± SE) in the first 8
weeks of lactation of Holstein cows treated with Imrestor or saline control.
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